- Milli Expanding Vaginal Dilator’s Regulatory Arc: Wellness to Rx to OTC
- Market told us robust clinical would support adoption—need to do fast and cheap
- Developing the study protocol and clinical operations POMPOM – Milli
- Recruitment strategies and metrics
- Remote data collection and compensation
- Baseline Data Abstract accepted by ISSWSH
- What we learned
- Future studies: lather-rinse-repeat
